Literature DB >> 16364836

Effects of different classes of antihypertensive drugs on cerebral hemodynamics in elderly hypertensive patients.

Chin-Hua Fu1, Cheryl C H Yang, Terry B J Kuo.   

Abstract

BACKGROUND: This study was designed to estimate the effect of different classes of antihypertensive drugs on cerebral hemodynamics in elderly stroke-free, nondiabetic hypertensive patients by applying frequency-domain techniques.
METHODS: A total of 60 hypertensive patients divided into treatment groups of 15 unmedicated (HT), 15 nifedepine sustained release form (CCB), 15 atenolol (BB), and 15 valsartan (AIIA), and 15 age-matched healthy volunteers (CON) were studied prospectively. Variability of arterial blood pressure (ABP) and middle cerebral artery flow velocity (MCAFV) detected by transcranial Doppler sonography were diffracted into very-low frequency (VLF, 0.016 to 0.04 Hz), low frequency (LF, 0.04 to 0.15 Hz), and high frequency (HF, 0.15 to 0.4 Hz). Cerebral hemodynamics was quantified by the ABP-MCAFV transfer function.
RESULTS: The ABP and MCAFV were statistically different between CON and HT groups, but not significantly different among CON, CCB, BB, and AIIA groups. The LF phase and HF magnitude in the HT, CCB, and BB groups were significantly attenuated than in those of the CON group, but not statistically different between the AIIA and CON groups. There was no statistical difference in VLF and LF transfer magnitude among the five groups.
CONCLUSIONS: Although cerebral vasomotor reserve and cerebral blood flow are impaired in unmedicated hypertensive patients, the cerebral autoregulatory response was preserved both in controlled and uncontrolled hypertension. Nifedipine, atenolol, and valsartan are all effective as monotherapy to control ABP and restore cerebral blood flow. Valsartan has the effect to normalize the changes in cerebral vasomotor reserve to a level similar as in age-matched healthy subjects.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16364836     DOI: 10.1016/j.amjhyper.2005.05.015

Source DB:  PubMed          Journal:  Am J Hypertens        ISSN: 0895-7061            Impact factor:   2.689


  8 in total

1.  Brain function, cognition, and the blood pressure response to pharmacological treatment.

Authors:  J Richard Jennings; Israel C Christie; Matthew F Muldoon; Christopher M Ryan; Julie C Price; Carolyn C Meltzer
Journal:  Psychosom Med       Date:  2010-07-16       Impact factor: 4.312

Review 2.  Effect of drug interventions on cerebral hemodynamics in ischemic stroke patients.

Authors:  Osian Llwyd; Jui-Lin Fan; Martin Müller
Journal:  J Cereb Blood Flow Metab       Date:  2021-11-05       Impact factor: 6.200

3.  A cerebrovascular response model for functional neuroimaging including dynamic cerebral autoregulation.

Authors:  Solomon Gilbert Diamond; Katherine L Perdue; David A Boas
Journal:  Math Biosci       Date:  2009-05-13       Impact factor: 2.144

4.  Cerebrovascular support for cognitive processing in hypertensive patients is altered by blood pressure treatment.

Authors:  J Richard Jennings; Matthew F Muldoon; Julie Price; Israel C Christie; Carolyn C Meltzer
Journal:  Hypertension       Date:  2008-06-02       Impact factor: 10.190

5.  Intima-media thickness of carotid artery and aortic pulse wave velocity as determinants of cerebral blood flow velocity.

Authors:  A Kwater; J Gąsowski; T Grodzicki
Journal:  J Hum Hypertens       Date:  2013-12-05       Impact factor: 3.012

6.  Effects of vasodilating medications on cerebral haemodynamics in health and disease: systematic review and meta-analysis.

Authors:  Alastair J S Webb
Journal:  J Hypertens       Date:  2019-06       Impact factor: 4.844

7.  Effect of Antihypertensive Treatment on Cerebral Blood Flow in Older Adults: a Systematic Review and Meta-Analysis.

Authors:  Anniek E van Rijssel; Bram C Stins; Lucy C Beishon; Marit L Sanders; Terence J Quinn; Jurgen A H R Claassen; Rianne A A de Heus
Journal:  Hypertension       Date:  2022-02-23       Impact factor: 10.190

8.  Impaired cerebral autoregulation is associated with poststroke cognitive impairment.

Authors:  Nai-Fang Chi; Han-Hwa Hu; Lung Chan; Cheng-Yen Wang; Shu-Ping Chao; Li-Kai Huang; Hsiao-Lun Ku; Chaur-Jong Hu
Journal:  Ann Clin Transl Neurol       Date:  2020-05-28       Impact factor: 4.511

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.